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In 2015, President Obama announced the US PrecisionMedi-
cine Initiative,1 and similarly, the European Union HORIZON
2020 Work Programme 2016 to 2017 called for personalized
medicineresearchtobetterunderstandhealth,preventandtreat
disease, and get people more
engagedinself-management.2
In this issue of JAMA Derma-
tology, Watts et al3 present
data thatmight beuseful for clinicians to keeppeople engaged
in examining their skin andmay help to better design person-
alized melanoma prevention and early detection interven-
tions.Wattsetal3classified2727patientswithmelanomaashav-
ing high or lower risk depending onwhether they already had
apersonalor familyhistoryofmelanoma,ormanynevi,ornone
of these3 factors.Theythenresearchedtheageatdiagnosisand
body site distribution of themelanomas for these patients. Pa-
tients classified as high riskwere younger, and in the high-risk
group those with family history or many nevi were signifi-
cantly younger compared with those with a prior personal
history of melanoma. The authors also reported significant
differences between risk groupswith regard to body site, with
high-riskpatientshavingmoremelanomasonthetrunk(notfur-
ther specified) and limbs,while lower riskpatientshadahigher
propensity for melanomas on the head and neck. These re-
sults fitwellwiththedivergentpathwayshypothesiswhichpro-
poses thatamongpeoplewith lowergenetic riskcumulativesun
exposurewill leadtomelanomaatchronicallysun-exposedsites
of the body.4
For patientswhoalreadyhad 1melanomadiagnosed, pre-
vious data by Youlden et al5 found that they were 5.4 times
more likely todevelopa subsequentprimarymelanomaat any
body site comparedwith the general population,with the sec-
ond primary melanoma significantly more likely to occur on
the same body site as the initial invasive or in situmelanoma.
Site-specific second melanomas were especially common
amongwomenwhose primarymelanomawas located on the
head, whowere found to have a standardized incidence ratio
of 13.32 for the second primary melanoma to also be on the
head. Cumulative sun exposure may play a role in this find-
ing from Australia were ultraviolet radiation levels are for
most of the year high to extreme in many regions. In a
population-based US study among young people with mela-
noma, women had more subsequent primary melanomas on
the extremities and were also more likely to develop subse-
quent primary melanomas at a different anatomical site,
while men developed more subsequent primary melanomas
on the trunk, head, and neck.6 Focusing on the early detec-
tion of second and third primary melanomas is important
because such events double or triple the risk of death 10
years after diagnosis of the first melanoma compared with
people who only develop 1 melanoma.7
Howcould thedata reportedbyWattsetal3beused inprac-
tice? Earlier this year, Robinson et al8 reported findings of a
landmarkrandomizedclinical trialofpartner-assistedskinself-
examination. They trainedpatients diagnosedwith stage0 to
2B melanoma and their partners in systematic skin self-
examination. This intervention significantly increased the
numberofmelanomas identifiedathome(interventiongroups,
395 patients; home-identified melanomas, 43; and 10 addi-
tionaldoctor identifiedmelanomasondifferentpatients)with-
out increasing unnecessary visits to the doctor.Most of these
new melanomas were stage 0 (in situ melanoma), and could
therefore be removed with minimal harm to the patient. Pa-
tients in thecontrolgroup,whodidnot receivestructuredtrain-
ing for skin self-examinationdidnot findanymelanomas (con-
trol group, 99 patients; home-identified melanomas, 0; and
16 melanomas were found by doctor). Robinson and col-
leagues now propose to test a web-based version of their in-
tervention, which would allow even greater personalization
than theworkbookor in-person trainingperformedduring the
trial. Oneobservationof the trialwas that, overall, about 40%
of the participants were lost to follow-up by 24months, with
a 10% greater loss to follow-up in the workbook or tablet in-
terventioncomparedwith in-persongroups,oftenbecausepa-
tients felt they were not learning anything new or there was
no change in their pigmented lesions. Personalizing the pro-
gramto thepatient’s ageorbodysiteof the firstmelanomamay
help engage the patients and their partnersmore deeplywith
such programs of self-examination. Regular text massage
remindersmaybeanotherway tokeeppatients and their part-
ners vigilant.9 Programs could be supplemented by patient-
performed dermoscopy,10,11 facilitating quick and cost-
effective communication between the patients and their
dermatologist.12 While recent data from a large case-control
study did not find a significant reduction of mortality from
melanoma for people who performed skin self-examination
once they adjusted for competingmortality and covariates, a
significantbenefit for skinawarenesswas found(HR,0.46;95%
CI,0.28-0.75;P ≤ .01).13Apatient’s cognitiveprocesses for skin
awareness are complex, involvingdifferential, analytical, pat-
tern, and comparative recognition in addition to contextual
factors, such as experience and time pressure,14 and could
potentially be eased by dermoscopy and availability of pho-
tographic documentation.15
The data presented by Watts et al3 are therefore very
useful in the spirit of personalized medicine. They allow
initiating a discussion with patients with melanoma or
persons at risk of melanoma about partner-assisted skin
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self-examination, how to perform it regularly and consis-
tently over time, and how to best remind and engage
patients with regular self-examination and self-monitoring
of new or changing nevi. In this context dermatologists may
highlight that people with many nevi or those with a family
history of melanoma need to start partner-assisted skin self-
examination and monitoring at an earlier age than other
people, and discuss the body sites that require particular
attention given the person’s risk status. Body site discus-
sions are important more broadly because people may be
more inclined to inspect easily visible areas of their body
than the back or back of the neck.10
ARTICLE INFORMATION
Author Affiliations: School of Public Health and
Social Work, Institute of Health and Biomedical
Innovation, Queensland University of Technology,
Brisbane, Australia (Janda); Dermatology Research
Centre, The University of Queensland, School of
Medicine, Translational Research Institute,
Brisbane, Queensland, Australia (Soyer).
Corresponding Author:Monika Janda, PhD, School
of Public Health and Social Work, Institute of Health
and Biomedical Innovation, Queensland University
of Technology, Brisbane, Australia (m.janda@qut
.edu.au).
Published Online:November 9, 2016.
doi:10.1001/jamadermatol.2016.3472
Conflict of Interest Disclosures:H. Peter Soyer is a
shareholder of e-derm consult GmbH andMoleMap
by Dermatologists Ltd Pty. He provides
teledermatological reports regularly for both
companies. No other disclosures are reported.
REFERENCES
1. National Institutes of Health. PrecisionMedicine
Initiative Cohort Program. https://www.nih.gov
/precision-medicine-initiative-cohort-program.
Accessed July 25, 2016.
2. European Commission. Horizon 2020work
programme for 2016-2017. http://ec.europa.eu
/research/participants/portal/desktop/en/funding
/reference_docs.html#h2020-work
-programmes-2016-17. Accessed July 25, 2016.
3. Watts CG, Madronio C, Morten RL, et al. Clinical
features associated with individuals at higher risk of
melanoma: a population-based study [published
online November 9, 2016]. JAMA Dermatol.
doi: 10.1001/jamadermatol.2016.3327
4. Whiteman DC, Watt P, Purdie DM, Hughes MC,
Hayward NK, Green AC. Melanocytic nevi, solar
keratoses, and divergent pathways to cutaneous
melanoma. J Natl Cancer Inst. 2003;95(11):806-812.
5. Youlden DR, Youl PH, Soyer HP, Aitken JF, Baade
PD. Distribution of subsequent primary invasive
melanomas following a first primary invasive or in
situ melanoma Queensland, Australia, 1982-2010.
JAMA Dermatol. 2014;150(5):526-534.
6. Fu T, Swetter SM, Tao L, Geller AC, Clarke CA,
Keegan TH. Characterizing subsequent primary
melanomas (SPM) in adolescents and young adults:
A population-based study from 1973 to 2011. J Am
Acad Dermatol. 2016;74(1):181-182.e3.
7. Youlden DR, Baade PD, Peter Soyer H, et al.
Ten-year survival after multiple invasive melanomas
is worse than after a single melanoma:
a population-based study. J Invest Dermatol. 2016;
S0022-202X(16)30930-7. epub ahead of print.
8. Robinson JK, Wayne JD, Martini MC, Hultgren
BA, Mallett KA, Turrisi R. Early detection of new
melanomas by patients with melanoma and their
partners using a structured skin self-examination
skills training intervention: a randomized clinical
trial. JAMA Dermatol. 2016;152(9):979-985.
9. Youl PH, Soyer HP, Baade PD, Marshall AL, Finch
L, JandaM. Can skin cancer prevention and early
detection be improved via mobile phone text
messaging? a randomised, attention control trial.
Prev Med. 2015;71:50-56.
10. ManahanMN, Soyer HP, Loescher LJ, et al.
A pilot trial of mobile, patient-performed
teledermoscopy. Br J Dermatol. 2015;172(4):
1072-1080.
11. Wu X, Oliveria SA, Yagerman S, et al. Feasibility
and efficacy of patient-initiatedmobile
teledermoscopy for short-termmonitoring of
clinically atypical nevi. JAMA Dermatol. 2015;151(5):
489-496.
12. Snoswell C, Finnane A, JandaM, Soyer HP,
Whitty JA. Cost-effectiveness of store-and-forward
teledermatology: a systematic review. JAMA
Dermatol. 2016;152(6):702-708.
13. Paddock LE, Lu SE, Bandera EV, et al. Skin
self-examination and long-termmelanoma survival.
Melanoma Res. 2016;26(4):401-408.
14. Marghoob AA, Scope A. The complexity of
diagnosingmelanoma. J Invest Dermatol. 2009;129
(1):11-13.
15. Oliveria SA, Chau D, Christos PJ, Charles CA,
Mushlin AI, Halpern AC. Diagnostic accuracy of
patients in performing skin self-examination and
the impact of photography. Arch Dermatol. 2004;
140(1):57-62.
Editorial Opinion
jamadermatology.com (Reprinted) JAMADermatology January 2017 Volume 153, Number 1 19
Downloaded From:  by a UQ Library User  on 08/07/2018
